In a report released today, Vernon Bernardino from H.C. Wainwright reiterated a Buy rating on Cassava Sciences (SAVA - Research Report), with a price target of $124.00. The company's shares closed yesterday at $26.47.Bernardino covers the Healthcare sector, focusing on stocks such as Eledon Pharmaceuticals, Achieve Life Sciences, and Seres Therapeutics. According to TipRanks, Bernardino has an average return of 25.9% and a 37.30% success rate on recommended stocks. In addition to H.C. Wainwright, Cassava Sciences also received a Buy from JonesTrading's Soumit Roy in a report issued yesterday. However, on August 4, Univest Securities maintained a Sell rating on Cassava Sciences (NASDAQ: SAVA).
https://www.tipranks.com/news/blurbs/h-c-wainwright-remains-a-buy-on-cassava-sciences-sava?utm_source=advfn.com&utm_medium=referral
Cassava Sciences (NASDAQ:SAVA)
Historical Stock Chart
From Oct 2022 to Nov 2022 Click Here for more Cassava Sciences Charts.
Cassava Sciences (NASDAQ:SAVA)
Historical Stock Chart
From Nov 2021 to Nov 2022 Click Here for more Cassava Sciences Charts.